Statement on Biden-Harris Administration’s Buy American Act Proposed Rule
WASHINGTON, July 29, 2021 — The Biden-Harris Administration’s Buy American Act Proposed Rule is another step forward for boosting American production and manufacturing. SAMS commends the Administration’s efforts to close problematic loopholes in the Buy American statute, strengthen the domestic supply chain, and reward the grit and innovation of American companies and small businesses.
SAMS Member companies are eager to partner with the Administration and Congress on this rule and other important changes to strengthen and bolster the American and ally medical supply chains. Let us use the innovative and updated tools of the government — combined with ingenuity and resiliency of the private sector — to expand domestic critical supplies now.
About Securing America’s Medicines and Supply
Securing America’s Medicines and Supply (SAMS) is a multi-industry coalition of companies with the mission to strengthen the security of the medical supply chain in the United States. SAMS seeks to drive implementation of legislation and regulation to reward and foster U.S.-made manufacturing of important pharmaceutical products, devices, and supplies. SAMS supports U.S. patients, domestic healthcare security, and U.S. jobs.